Jamie Perse
Stock Analyst at Goldman Sachs
(3.14)
# 1,198
Out of 4,969 analysts
67
Total ratings
54.76%
Success rate
11.14%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jamie Perse
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AGL agilon health | Maintains: Neutral | $2.5 → $5 | $1.27 | +293.70% | 7 | May 8, 2025 | |
| THC Tenet Healthcare | Maintains: Neutral | $134 → $154 | $185.35 | -16.91% | 12 | May 5, 2025 | |
| LFST LifeStance Health Group | Upgrades: Buy | $10 | $5.63 | +77.62% | 7 | Dec 16, 2024 | |
| OPCH Option Care Health | Downgrades: Neutral | $38 → $27 | $28.44 | -5.06% | 3 | Nov 5, 2024 | |
| CON Concentra Group Holdings Parent | Initiates: Buy | $32 | $23.73 | +34.85% | 1 | Aug 19, 2024 | |
| BTSG BrightSpring Health Services | Maintains: Buy | $21 → $18 | $23.89 | -24.65% | 3 | Aug 9, 2024 | |
| UHS Universal Health Services | Maintains: Buy | $200 → $229 | $181.51 | +26.16% | 16 | Jul 30, 2024 | |
| INNV InnovAge Holding | Maintains: Neutral | $8 → $7 | $3.69 | +89.70% | 5 | Feb 8, 2024 | |
| HCA HCA Healthcare | Downgrades: Neutral | n/a | $406.14 | - | 10 | Dec 11, 2023 | |
| EHAB Enhabit | Maintains: Neutral | $15 → $13 | $7.90 | +64.66% | 2 | Jul 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $32 | $23.16 | +38.17% | 1 | Feb 3, 2023 |
agilon health
May 8, 2025
Maintains: Neutral
Price Target: $2.5 → $5
Current: $1.27
Upside: +293.70%
Tenet Healthcare
May 5, 2025
Maintains: Neutral
Price Target: $134 → $154
Current: $185.35
Upside: -16.91%
LifeStance Health Group
Dec 16, 2024
Upgrades: Buy
Price Target: $10
Current: $5.63
Upside: +77.62%
Option Care Health
Nov 5, 2024
Downgrades: Neutral
Price Target: $38 → $27
Current: $28.44
Upside: -5.06%
Concentra Group Holdings Parent
Aug 19, 2024
Initiates: Buy
Price Target: $32
Current: $23.73
Upside: +34.85%
BrightSpring Health Services
Aug 9, 2024
Maintains: Buy
Price Target: $21 → $18
Current: $23.89
Upside: -24.65%
Universal Health Services
Jul 30, 2024
Maintains: Buy
Price Target: $200 → $229
Current: $181.51
Upside: +26.16%
InnovAge Holding
Feb 8, 2024
Maintains: Neutral
Price Target: $8 → $7
Current: $3.69
Upside: +89.70%
HCA Healthcare
Dec 11, 2023
Downgrades: Neutral
Price Target: n/a
Current: $406.14
Upside: -
Enhabit
Jul 17, 2023
Maintains: Neutral
Price Target: $15 → $13
Current: $7.90
Upside: +64.66%
Feb 3, 2023
Initiates: Buy
Price Target: $32
Current: $23.16
Upside: +38.17%